While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for meds like Ozempic and Zepbound has decreased.

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

A person can get Zepbound through Medicare Part D or Part C plans with drug coverage to treat this condition ... you in making personal decisions about insurance, but it is not intended to ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A month’s supply of a 10 mg Zepbound pen will run you over $1,000 without insurance. Through LillyDirect, consumers without insurance coverage can get a 10 mg vial for under $600. Drug companies ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

LifeMD’s virtual care services now available to over 21 million Medicare Part B beneficiaries in 26 states, with 49-state access to qualifying services expected by the end of Q2NEW YORK, April 17, ...

Last week, the Centers for Medicare & Medicaid Services said it will not go ahead with a plan from the Biden administration ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.